Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 30, 2024 | (FY)Dec 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 71.71%442.12M | 257.48M | ||||||||
| Operating revenue | 71.71%442.12M | --257.48M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cost of revenue | 94.58M | |||||||||
| Gross profit | 171.39%442.12M | 162.91M | ||||||||
| Operating expense | 168.03%409.53M | 1,279.50%152.79M | 23.34%11.08M | 300.17%8.98M | 131.14%2.24M | -72.22%970.85K | 421.12%3.49M | -2.08%670.66K | -14.13%684.93K | 27.53%797.61K |
| Selling and administrative expenses | -39.36%29.19M | 1,021.60%48.14M | 240.28%4.29M | 260.25%1.26M | 89.53%350.11K | -75.30%184.73K | 152.76%747.8K | 58.70%295.86K | -38.51%186.43K | -22.17%303.21K |
| -Selling and marketing expense | 72.86%6.03M | 117.83%3.49M | 1,599.33%1.6M | 625.43%94.25K | 23.68%12.99K | -86.87%10.51K | --80.01K | ---- | -87.52%5.5K | -52.15%44.05K |
| -General and administrative expense | -48.13%23.16M | 1,559.69%44.65M | 130.52%2.69M | 246.18%1.17M | 93.50%337.12K | -73.91%174.22K | 125.71%667.79K | 63.52%295.86K | -30.18%180.94K | -12.90%259.16K |
| Depreciation amortization depletion | 16.70%51.23M | 34,553.42%43.9M | 21,910.25%126.67K | --575.5244 | ---- | ---- | ---- | ---- | ---- | -79.41%8.63K |
| -Depreciation and amortization | 16.70%51.23M | 34,553.42%43.9M | 21,910.25%126.67K | --575.5244 | ---- | ---- | ---- | ---- | ---- | -79.41%8.63K |
| Other operating expenses | 441.72%329.11M | 812.61%60.75M | -13.75%6.66M | 307.52%7.72M | 140.92%1.89M | -71.38%786.12K | 632.97%2.75M | -24.81%374.8K | 2.62%498.5K | 150.51%485.77K |
| Operating profit | 222.06%32.59M | 191.37%10.12M | -23.34%-11.08M | -300.17%-8.98M | -131.14%-2.24M | 72.22%-970.85K | -421.12%-3.49M | 2.08%-670.66K | 14.13%-684.93K | -27.53%-797.61K |
| Net non-operating interest income (expenses) | -82.28%-20.91M | -415.66%-11.47M | -22,616.64%-2.22M | -52.27%9.88K | -50.03%20.7K | -19.65%41.42K | 183.75%51.55K | -5.37%18.17K | -37.26%19.2K | -69.93%30.6K |
| Non-operating interest income | 142.42%6.51M | 77,174.42%2.69M | -64.83%3.47K | -52.27%9.88K | -50.03%20.7K | -19.65%41.42K | 183.75%51.55K | -6.49%18.17K | -37.07%19.43K | -69.73%30.87K |
| Non-operating interest expense | 95.24%25.71M | 490.99%13.17M | --2.23M | ---- | ---- | ---- | ---- | ---- | -15.76%230.0087 | 19.35%273.0522 |
| Total other finance cost | 73.00%1.71M | --989K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -1,264.36%-144.75M | 4,904.46%12.43M | -91.10%-258.76K | -678.04%-135.4K | 23.42K | 94.43%-26.13K | -123.45%-468.71K | 1,720.77%2M | 106.69%109.78K | |
| Special income (charges) | ---151.62M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | --151.62M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -44.76%6.87M | 4,904.46%12.43M | -91.10%-258.76K | -678.04%-135.4K | --23.42K | ---- | 94.43%-26.13K | -123.45%-468.71K | 1,720.77%2M | -87.28%109.78K |
| Income before tax | -1,300.76%-133.07M | 181.73%11.08M | -48.92%-13.56M | -313.87%-9.1M | -136.69%-2.2M | 73.21%-929.43K | -209.45%-3.47M | -184.10%-1.12M | 302.85%1.33M | 69.64%-657.23K |
| Income tax | -404.57%-35.81M | 11.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -14,287.13%-97.26M | 95.01%-676K | -48.92%-13.56M | -313.87%-9.1M | -136.69%-2.2M | 73.21%-929.43K | -209.45%-3.47M | -184.10%-1.12M | 302.85%1.33M | 69.64%-657.23K |
| Net income continuous operations | -14,287.13%-97.26M | 95.01%-676K | -48.92%-13.56M | -313.87%-9.1M | -136.69%-2.2M | 73.21%-929.43K | -209.45%-3.47M | -184.10%-1.12M | 302.85%1.33M | 69.64%-657.23K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -14,287.13%-97.26M | 95.01%-676K | -48.92%-13.56M | -313.87%-9.1M | -136.69%-2.2M | 73.21%-929.43K | -209.45%-3.47M | -184.10%-1.12M | 302.85%1.33M | 69.64%-657.23K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -14,287.13%-97.26M | 95.01%-676K | -48.92%-13.56M | -313.87%-9.1M | -136.69%-2.2M | 73.21%-929.43K | -209.45%-3.47M | -184.10%-1.12M | 302.85%1.33M | 69.64%-657.23K |
| Diluted earnings per share | -13,580.00%-0.0684 | 98.77%-0.0005 | -12.64%-0.0408 | -117.79%-0.0362 | -126.11%-0.0166 | 76.99%-0.0074 | -118.85%-0.032 | -184.28%-0.0146 | 305.35%0.0173 | 72.00%-0.0084 |
| Basic earnings per share | -13,580.00%-0.0684 | 98.77%-0.0005 | -12.64%-0.0408 | -117.79%-0.0362 | -126.11%-0.0166 | 76.99%-0.0074 | -118.85%-0.032 | -184.28%-0.0146 | 305.35%0.0173 | 72.00%-0.0084 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |